Iannitto, E., Luminari, S., Tripodo, C., Mancuso, S., Cesaretti, M., Marcheselli, L., Merli, F., Stelitano, C., Carella, A. M., Fragasso, A., Montechiarello, E., Ricciuti, G., Pulsoni, A., Paulli, M., Franco, V., & Federico, M. (n.d.). rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study. Leukemia & lymphoma, 56(12), 3281–3287. http://access.bl.uk/ark:/81055/vdc_100089569141.0x000026